EGFR and familial pancreatic carcinoma: A previous research showed that the tumor marker CA 19-9 itself promotes the activation of EGFR (Epidermal Growth Factor Receptor) signaling in mice, suggesting an important role in the initiation and acceleration of pancreatic cancer [32].